AP2015008674A0 - A novel composition for nonalcoholic fatty liver disease (NAFLD) - Google Patents
A novel composition for nonalcoholic fatty liver disease (NAFLD)Info
- Publication number
- AP2015008674A0 AP2015008674A0 AP2015008674A AP2015008674A AP2015008674A0 AP 2015008674 A0 AP2015008674 A0 AP 2015008674A0 AP 2015008674 A AP2015008674 A AP 2015008674A AP 2015008674 A AP2015008674 A AP 2015008674A AP 2015008674 A0 AP2015008674 A0 AP 2015008674A0
- Authority
- AP
- ARIPO
- Prior art keywords
- nafld
- liver disease
- fatty liver
- novel composition
- nonalcoholic fatty
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2013/000391 WO2014174524A1 (en) | 2013-04-22 | 2013-06-25 | A novel composition for nonalcoholic fatty liver disease (nafld) |
| IN1468MU2013 IN2013MU01468A (es) | 2013-04-22 | 2013-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2015008674A0 true AP2015008674A0 (en) | 2015-08-31 |
Family
ID=49253372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2015008674A AP2015008674A0 (en) | 2013-04-22 | 2013-06-25 | A novel composition for nonalcoholic fatty liver disease (NAFLD) |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20160166539A1 (es) |
| EP (1) | EP2988736A1 (es) |
| JP (1) | JP6246895B2 (es) |
| KR (1) | KR101617812B1 (es) |
| CN (1) | CN105377246B (es) |
| AP (1) | AP2015008674A0 (es) |
| AU (1) | AU2013387996B2 (es) |
| BR (1) | BR112015020600A2 (es) |
| CA (1) | CA2900435C (es) |
| EA (1) | EA201592020A1 (es) |
| GE (1) | GEP201706663B (es) |
| HK (1) | HK1214968A1 (es) |
| IL (2) | IL240183A (es) |
| IN (1) | IN2013MU01468A (es) |
| MA (1) | MA38385A1 (es) |
| MX (1) | MX346943B (es) |
| MY (1) | MY180160A (es) |
| PH (1) | PH12015501795A1 (es) |
| SG (1) | SG11201506218UA (es) |
| UA (1) | UA114360C2 (es) |
| WO (1) | WO2014174524A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107056671A (zh) | 2011-01-31 | 2017-08-18 | 卡迪拉保健有限公司 | 脂肪代谢障碍的治疗 |
| US20130158077A1 (en) | 2011-12-19 | 2013-06-20 | Ares Trading S.A. | Pharmaceutical compositions |
| EA201592020A1 (ru) | 2013-04-22 | 2016-05-31 | Кадила Хелзкэр Лимитед | Новая композиция для неалкогольной жировой болезни печени (нажбп) |
| ES2889916T3 (es) | 2013-05-30 | 2022-01-14 | Cadila Healthcare Ltd | Un procedimiento para la preparación de pirroles con actividades hipolipidémicas e hipocolesterémicas |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (es) * | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
| WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| WO2018104916A1 (en) * | 2016-12-09 | 2018-06-14 | Cadila Healthcare Limited | Treatment for primary biliary cholangitis |
| KR20190126920A (ko) | 2017-03-28 | 2019-11-12 | 길리애드 사이언시즈, 인코포레이티드 | 간 질환을 치료하기 위한 치료 조합물 |
| GB201710229D0 (en) * | 2017-06-27 | 2017-08-09 | Tdeltas Ltd | Compounds for new use |
| CA3077273A1 (en) * | 2017-10-06 | 2019-04-11 | Gilead Sciences, Inc. | Combination therapy comprising an acc inhibitor |
| CN109675016A (zh) * | 2017-10-18 | 2019-04-26 | 上海贺普药业股份有限公司 | 非酒精性脂肪性肝病的治疗药物 |
| CN110934866B (zh) * | 2018-09-25 | 2023-12-01 | 深圳微芯生物科技股份有限公司 | 西格列羧及其相关化合物的应用 |
| US20220071954A1 (en) * | 2018-12-18 | 2022-03-10 | Cadila Healthcare Limited | Saroglitazar for the treatment of hepatocellular carcinoma |
| US20220175721A1 (en) * | 2019-02-13 | 2022-06-09 | Cadila Healthcare Limited | Treatment for polycystic ovarian syndrome (pcos) |
| US20220378786A1 (en) * | 2021-05-21 | 2022-12-01 | HepQuant, LLC | Methods of defining functional change and slowing progression in chronic liver disease |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| EP0648212B1 (en) | 1992-07-03 | 2001-10-24 | Smithkline Beecham Plc | Benzoxazole and benzothiazole derivatives as pharmaceutical |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| US5387613A (en) | 1993-07-23 | 1995-02-07 | Ribogene, Inc. | Treatment of tachyarrhythmias of supraventricular origin |
| GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
| BR9508468A (pt) | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário |
| PT826688E (pt) | 1995-04-28 | 2002-02-28 | Daiichi Seiyaku Co | Composto pentaciclico |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| WO1999019313A1 (en) | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| US6130214A (en) | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
| DE69828445D1 (de) | 1998-04-23 | 2005-02-03 | Reddys Lab Ltd Dr | Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen |
| CN100357281C (zh) | 1998-05-27 | 2007-12-26 | 雷迪实验室有限公司 | 双环化合物、其制备方法和包含它们的药物组合物 |
| WO2000023445A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| JP2002527520A (ja) | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | 新規化合物、その製造及び使用 |
| JP2002527503A (ja) | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | 新規化合物類、それらの調製及び使用 |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| EE05082B1 (et) | 2000-01-19 | 2008-10-15 | Cadila Healthcare Ltd. | Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| AU2001286163A1 (en) | 2000-09-22 | 2002-04-02 | Dr. Reddy's Research Foundation | An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US6987123B2 (en) * | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| WO2005031335A1 (ja) | 2003-09-26 | 2005-04-07 | Mitsubishi Rayon Co., Ltd. | 電気泳動装置および電気泳動法並びにそれを用いた生体関連物質の検出方法 |
| CN102134230B (zh) | 2004-03-15 | 2019-06-28 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
| US20070087987A1 (en) * | 2005-09-19 | 2007-04-19 | Monia Brett P | Modulation of glucagon receptor expression |
| WO2008036638A2 (en) * | 2006-09-18 | 2008-03-27 | Alnylam Pharmaceuticals, Inc. | Rnai modulation of scap and therapeutic uses thereof |
| JP2008184429A (ja) * | 2007-01-30 | 2008-08-14 | Japan Health Science Foundation | 肝臓トリグリセリド濃度低下剤 |
| CA2781451C (en) | 2009-11-26 | 2019-04-16 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| CN103347506A (zh) | 2010-10-12 | 2013-10-09 | 约翰.霍普金斯大学 | 包含美金刚的镇咳组合物 |
| CN107056671A (zh) | 2011-01-31 | 2017-08-18 | 卡迪拉保健有限公司 | 脂肪代谢障碍的治疗 |
| EA201592020A1 (ru) | 2013-04-22 | 2016-05-31 | Кадила Хелзкэр Лимитед | Новая композиция для неалкогольной жировой болезни печени (нажбп) |
| ES2889916T3 (es) | 2013-05-30 | 2022-01-14 | Cadila Healthcare Ltd | Un procedimiento para la preparación de pirroles con actividades hipolipidémicas e hipocolesterémicas |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (es) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| IN2013MU02828A (es) | 2013-08-29 | 2015-07-03 | Cadila Healthcare Ltd | |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
-
2013
- 2013-06-25 EA EA201592020A patent/EA201592020A1/ru unknown
- 2013-06-25 AU AU2013387996A patent/AU2013387996B2/en not_active Ceased
- 2013-06-25 UA UAA201509744A patent/UA114360C2/uk unknown
- 2013-06-25 MX MX2015010769A patent/MX346943B/es active IP Right Grant
- 2013-06-25 AP AP2015008674A patent/AP2015008674A0/xx unknown
- 2013-06-25 CA CA2900435A patent/CA2900435C/en not_active Expired - Fee Related
- 2013-06-25 BR BR112015020600A patent/BR112015020600A2/pt not_active IP Right Cessation
- 2013-06-25 JP JP2016505927A patent/JP6246895B2/ja active Active
- 2013-06-25 IN IN1468MU2013 patent/IN2013MU01468A/en unknown
- 2013-06-25 KR KR1020157024370A patent/KR101617812B1/ko active IP Right Grant
- 2013-06-25 WO PCT/IN2013/000391 patent/WO2014174524A1/en active Application Filing
- 2013-06-25 MA MA38385A patent/MA38385A1/fr unknown
- 2013-06-25 MY MYPI2015002026A patent/MY180160A/en unknown
- 2013-06-25 EP EP13767126.9A patent/EP2988736A1/en not_active Withdrawn
- 2013-06-25 US US14/782,609 patent/US20160166539A1/en not_active Abandoned
- 2013-06-25 GE GEAP201313941A patent/GEP201706663B/en unknown
- 2013-06-25 SG SG11201506218UA patent/SG11201506218UA/en unknown
- 2013-06-25 CN CN201380075905.9A patent/CN105377246B/zh active Active
-
2015
- 2015-07-28 IL IL240183A patent/IL240183A/en not_active IP Right Cessation
- 2015-08-14 PH PH12015501795A patent/PH12015501795A1/en unknown
-
2016
- 2016-03-15 HK HK16103017.5A patent/HK1214968A1/zh unknown
- 2016-08-11 IL IL247231A patent/IL247231A/en not_active IP Right Cessation
- 2016-11-04 US US15/343,859 patent/US9814697B2/en active Active
-
2017
- 2017-11-02 US US15/801,738 patent/US20180185330A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1214968A1 (zh) | 2016-08-12 |
| KR101617812B1 (ko) | 2016-05-03 |
| IN2013MU01468A (es) | 2015-04-17 |
| US20160166539A1 (en) | 2016-06-16 |
| JP6246895B2 (ja) | 2017-12-13 |
| WO2014174524A1 (en) | 2014-10-30 |
| US20180185330A1 (en) | 2018-07-05 |
| CA2900435A1 (en) | 2014-10-30 |
| KR20150118990A (ko) | 2015-10-23 |
| GEP201706663B (en) | 2017-05-10 |
| CA2900435C (en) | 2017-02-14 |
| EP2988736A1 (en) | 2016-03-02 |
| WO2014174524A8 (en) | 2015-10-01 |
| JP2016515608A (ja) | 2016-05-30 |
| SG11201506218UA (en) | 2015-09-29 |
| MX346943B (es) | 2017-04-06 |
| UA114360C2 (uk) | 2017-05-25 |
| MY180160A (en) | 2020-11-23 |
| MA38385A1 (fr) | 2017-09-29 |
| EA201592020A1 (ru) | 2016-05-31 |
| IL240183A (en) | 2016-08-31 |
| IL240183A0 (en) | 2015-09-24 |
| AU2013387996B2 (en) | 2015-12-10 |
| IL247231A (en) | 2017-03-30 |
| US20170087127A1 (en) | 2017-03-30 |
| MX2015010769A (es) | 2015-11-26 |
| CN105377246B (zh) | 2018-03-20 |
| CN105377246A (zh) | 2016-03-02 |
| BR112015020600A2 (pt) | 2017-07-18 |
| PH12015501795A1 (en) | 2015-11-09 |
| AU2013387996A1 (en) | 2015-09-24 |
| US9814697B2 (en) | 2017-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1214968A1 (zh) | 用於非酒精性脂肪肝病 的新組合物 | |
| IL279395A (en) | A vaccine | |
| HK1220251A1 (zh) | 非酒精性脂肪性肝病 和非酒精性脂肪性肝炎 的生物標記物及其用途 | |
| EP2979681A4 (en) | CURABLE COMPOSITION | |
| EP3006511A4 (en) | VULCANIZABLE COMPOSITION | |
| EP2938863A4 (en) | MECHANICAL LINK FOR A SEGMENTED THERMAL SCREEN | |
| PL2839750T3 (pl) | Kompozycja tłuszczowa | |
| AU352807S (en) | Dispenser for curable compositions | |
| ZA201600241B (en) | Water-resistant composition | |
| EP3090749C0 (en) | NUTRIENT COMPOSITION WITH EFFECT TO IMPROVE FAT METABOLISM | |
| PL2956010T3 (pl) | Kompozycja tłuszczów | |
| HK1218877A1 (zh) | 粘膜疫苗組合物 | |
| IL244407A0 (en) | A multi-part acrylic preparation that can be hardened | |
| GB201305984D0 (en) | Mechanical linkage | |
| EP2977406A4 (en) | HARDENING COMPOSITION | |
| EP2960297A4 (en) | HARDENING COMPOSITION | |
| EP2819668A4 (en) | COMPOSITIONS OF RITONAVIR | |
| HK1219054A1 (zh) | 粘膜疫苗組合物 | |
| GB2535880B (en) | Two-part set-delayed cement compositions | |
| GB2534747B (en) | Automatic image composer | |
| EP2982716A4 (en) | HARDENING COMPOSITION | |
| EP2960296A4 (en) | HARDENING COMPOSITION | |
| GB201311067D0 (en) | Dual curable composition | |
| SG11201600573VA (en) | Curable compositions | |
| EP2960295A4 (en) | HARDENING COMPOSITION |